10月20日，哈门那盘中上涨3.01%，报427.4825美元／股，成交额1.08亿美元。
近期消息面上，多家机构在公司披露医保优势计划星级改善后连续上调目标价，最新包括瑞银将目标价上调至495美元，瑞穗也将目标价由468美元上调至495美元，奥本海默升至475美元，巴克莱更升至582美元。
此外，公司此前宣布与贝莱德旗下基金组建新合资企业，共同管理和运营近150家CenterWell老年初级保健诊所，并计划未来两年追加资本用于临床运营、新设诊所及并购，强化其医疗服务布局。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.